New business is being written on visibly better terms than the company's own recent norm, and the mix shift has just beg
The model's full reasoning — Q2 2022 call → NOThe user wants me to analyze the earnings call transcript to determine if management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement has only begun to flow into reported results. Let me analyze the transcript carefully. Key points from the transcript: 1. The main issue discussed is the "grocer issue" - a dispute with a major grocery chain that caused a significant revenue hit. The grocer issue was recently addressed. 2. Regarding pricing at the grocer: Trevor says "some GoodRx prices at the grocery will now be higher for consumers they were previously. But the prices are discounted relative to what users might otherwise pay, and we believe they are sustainable for all parties." 3. Karsten says: "we expect that pricing for most medications at the grocer will now be more similar to those in other retailers." 4. Karsten also says: "take rate will likely go down formulaically simply because as prices go up, all else held constant, that larger denominator means that the take rate as a functional will fall." So the pricing at the grocer is going UP (higher prices for consumers), which means the take rate (GoodRx's fee as a percentage) will go DOWN. This is not an improvement in the economics of the business - it's actually a deterioration. 5. The company is also implementing "consumer engagement efforts" that add friction to the funnel, which will negatively impact conversion and revenue. 6. The company is not providing full year guidance because the impact is uncertain. 7. The company expects the grocer issue to continue impacting revenue in Q3 and Q4. 8.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| BRKL | Brookline Bancorp, Inc. | Q2 2022 | 2022-07-30 | B+ |
| INVH | Invitation Homes Inc. | Q2 2022 | 2022-07-28 | B+ |
| MTB | M&T Bank Corporation | Q2 2022 | 2022-07-20 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| GNK | Genco Shipping & Trading Limited | Q2 2021 | 2021-08-07 | A |
| ESS | Essex Property Trust, Inc. | Q2 2018 | 2018-08-03 | B+ |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
CRL · Q2 2022 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management's comments on Safety Assessment pricing and backlog directly address both required elements: they describe current bookings and backlog at "escalating prices" and "meaningful price increases" that are already achieved on real transactions (not targets or future expectations), while noting that the reported Q2 results are still dominated by older 2022 terms and that the stronger pricing is accelerating into H2 and 2023 bookings.
ESS · Q2 2018 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management describes the loss-to-lease metric rising to 3.
CTO · Q2 2023 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...